Trial intelligence / Profile preview

ACTS: Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis

NCT03389555Phase 3Completed

Sponsor
Beth Israel Deaconess Medical Center
Start
Feb 2018
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ascorbic acid, hydrocortisone, thiamine in sepsis, septic shock, sponsored by Beth Israel Deaconess Medical Center. Started Feb 2018; status: completed.

02

Drugs

ascorbic acidhydrocortisonethiamine
03

Conditions

sepsisseptic shock

Beyond the preview

Go deeper on NCT03389555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03389555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call